Evotec SE (ETR:EVT)
3.404
+0.084 (2.53%)
Aug 19, 2026, 5:37 PM CET
Evotec SE Market Cap
Evotec SE has a market cap or net worth of €605.06 million as of August 19, 2026. Its market cap has decreased by -46.08% in one year.
Market Cap
605.06M
Enterprise Value
615.34M
Revenue
717.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.40
ChartMarket Cap Chart
Since November 11, 1999, Evotec SE's market cap has increased from 4.47M to 605.06M, an increase of 13,430.73%. That is a compound annual growth rate of 20.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 605.06M | -37.39% |
| Dec 30, 2025 | 966.41M | -33.49% |
| Dec 30, 2024 | 1.45B | -61.41% |
| Dec 29, 2023 | 3.77B | 39.63% |
| Dec 30, 2022 | 2.70B | -63.78% |
| Dec 30, 2021 | 7.44B | 50.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.46B |
| Bayer Aktiengesellschaft | 47.88B |
| Siemens Healthineers AG | 43.92B |
| Fresenius SE & Co. KGaA | 26.32B |
| Redcare Pharmacy NV | 1.29B |
| RHÖN-KLINIKUM Aktiengesellschaft | 990.69M |
| Gerresheimer AG | 966.43M |
| Eckert & Ziegler SE | 834.15M |